Connie Kawai
University of Southern California
3 Papers
61 Citations
Connie Kawai is an academic researcher from University of Southern California. The author has contributed to research in topics: Placebo & Rasagiline. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
Karl Kieburtz,Bernard Ravina,Bernard Ravina,Wendy R. Galpern,Barbara C. Tilley,Kathleen M. Shannon,Caroline M. Tanner,G. Frederick Wooten,Robert W. Hamill,Jacob I. Sage,Emily Kosa,Ray L. Watts,Natividad R. Stover,Rebecca McMurray,Mark F. Lew,Connie Kawai,David Coffey,Pauline LeBlanc,Julie H. Carter,Matthew Brodsky,Pamela Andrews,Andrew Siderowf,Sue Reichwein,Lisa M. Shulman,William J. Weiner,Katharine Pabst,Jeana Jaglin,Robert A. Hauser,Theresa McClain,Holly Delgado,Oksana Suchowersky,Lorelei Derwent,Jayaraman Rao,Maureen Cook,Michael J. Aminoff,Chad W. Christine,Jessie Roth,Maureen A. Leehey,Jacci Bainbridge,G. Webster Ross,Stephanie Terashita,Carlos Singer,Marian A. Perez,Anita Blenke,Brad A. Racette,Patricia Deppen,Rodger J. Elble,Charlene Young,Tracy Stewart,Kapil D. Sethi,Buff Dill,John W. Taylor,Peggy Roberge,Richard B. Dewey,Brigid Hayward,Joseph Jankovic,Christine Hunter,Frederick Wooten,Margaret F. Keller,Danna Jennings,Tammie Kelsey,W.R. Wayne Martin,Germaine McInnes,Joanne Wojcieszek,Joann Belden,Roger L. Albin,Kristine Wernette,Joseph M. Savitt,Becky Dunlop,Rajesh Pahwa,Kelly E. Lyons,Amy Parsons,John Y. Fang,Dorothy Shearon,Andrew Feigin,Margaret Marie Cox,Charles H. Adler,Marlene Lind,Burton L. Scott,Joanne Field,Martha Nance,Susan Peterson,Richard S. Burns,Lynn Marlor,I. Van Bodis-Wollner,Elizabeth Hayes,Jay S. Schneider,Stephanie Sendek,Stephen Gollomp,Gwyn Vernon,Peter A LeWitt,Maryan DeAngelis,David Simon,Linda Paul,Jay M. Gorell,Shana Krstevska,Marilyn Flewellen,Sharon McCarthy,Ryan J. Uitti,Margaret F. Turk,James H. Bower,Susan Torgrimson,Marwan N. Sabbagh,Zoran Obradov,Jorge L. Juncos,Mary Louise Musante Weeks,Hubert H. Fernandez,Gordon H. Brown,Jordan J. Elm,Paulo Guimaraes,Peng Huang,Yuko Y. Palesch,Cornelia Kamp,Aileen Shinaman,Debbie Fraser,Alicia Brocht,Susan Bennett,Chris Weaver,Debbie Baker,Beverly Olsen,Christopher G. Goetz,Janis M. Miyasaki,Susan C. Fagan,Patrick D. Mauldin +123 more
TL;DR: Coenzyme Q10 and GPI-1485 may warrant further study in Parkinson disease, although the data are inconsistent, and additional factors should be considered in the selection of agents for Phase III studies.
225
Rasagiline improves quality of life in patients with early Parkinson's disease
Kevin M. Biglan,Steven R. Schwid,Shirley Eberly,Karen Blindauer,S. Fahn,Tamar Goren,Karl Kieburtz,David Oakes,Sandra Plumb,Andrew Siderowf,Matthew B. Stern,Ira Shoulson,Denni Day,Aileen Shinaman,Mark F. Lew,Connie Kawai,Howard I. Hurtig,Mary Lloyd,Robert A. Hauser,Lisa Gauger,Robert E. Wood,Lawrence I. Golbe,Joanne Wojcieszek,Joann Belden,Andrew Feigin,Mary Lou Klimek,Barbara Shannon,William G. Ondo,Christine Hunter,Vincent Calabrese,Paul Atchinson,Frederick J. Marshall,Debra Berry,Irenita Gardiner,Janis M. Miyasaki,Luisa Del Rizzo,Tilak Mendis,Neila Mendis,Peggy Gray,Jean P. Hubble,Karen Betcher,Rajesh Pahwa,Eric Molho,Diane Brown,Sharon Evans,Lisa M. Shulman,Ali H. Rajput,Marianne Ewanishin,Mark Stacy,Kelli Williamson,John M. Bertoni,Carolyn Peterson,Paul J. Tuite,Brenda Ebbitt,Kathleen M. Shannon,Jean A. Jaglin,Caroline Taner,Kenneth Marek,Karen Stavris,Michael J. Aminoff,Mariaane DiMinno,Glenna A. Dowling,Un Jung Kang,Judy Richman,Kapil D. Sethi,W.R. Wayne Martin,Pamela King,Germaine McInnes,Charles H. Adler,Marlene Lind,Peter A. LeWitt,Maryan DeAngelis,Mark Forrest Gordon,Roberta Winnick,Robert G. Feldman,Cathi A. Thomas,Kelly M. Conn,Alicia Brocht,Chris Chadwick,Jeannette Connolly,Susan Daigneault,Janice Bausch,Lee Josephson,Rosemary Oliva,Antonio Lang,Christopher Cox,Carrie Irvine,John G. Nutt,William B. White +88 more
TL;DR: Rasagiline improved QOL compared with placebo, and this QOL improvement appears to be accounted for primarily by the symptomatic benefit of rasagILine.
66
Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
Robert A. Hauser,Mark F. Lew,Howard I. Hurtig,William G. Ondo,Joanne Wojcieszek,Cheryl Fitzer-Attas,Frederick J. Marshall,Irenita Gardiner,Nancy Pearson,Debra Berry,Kathleen M. Shannon,Jean A. Jaglin,William G. Ondo,Christine Hunter,Cathy R. Anderson,Peter A. LeWitt,Patricia Kaminski,Dawn Miller,Maryan DeAngelis,Janis M. Miyasaki,Julie So,Lisa Johnston,Caroline M. Tanner,Tracy Stewart,Lisa Tagg,Sheila Everett,Georgia Germain,Mickie Welsh,Micki McCollister,Linda L. Mann,Carlos Singer,William C. Koller,William J. Weiner,Dinorah Bateman,Tilak Mendis,Melodie Moterson,Cynthia Alcorn-Costa,Keely Haas,Peggy Gray,Davoud Mohtat,Neila Mendis,Laura Sutherland,Howard H. Hurtig,Mary Lloyd,Mary Mathews,Robert Hauser,Lisa Gauger,Patricia Dyches,Cheryl Newcomb,Jean P. Hubble,Karen Betcher,Carolyn C. Weeks,Sandra K. Kostyk,Ali H. Rajput,Marlene Gerow,Linda Klassen,Marianne Ewasnishin,Lawrence I. Golb,Vanessa Patterson,Deborah L. Caputo,Patricia Seuffert,Rajesh Pahwa,Tamara Gales,Lorette J. Jenkins,Amy Parsons,Scott Cradr,Jovianna N. Wellinghoff,Shantelle Coe,Cheryl Armstrong,Connie Kawai,Katherine B. Hawthorne,Kellie Gelles,Xiaoming Lu,Suzanne W. Schuman,Cheryl Cooper,Kenneth Marek,Barbara Fussell,Karen Caplan,Erica Barnabei,Karen Stavris,Kapil D. Sethi,J. Carpenter,James B. Osborne,Shoba Narayan,K. Ligon,Eric Molho,Sharon Evans,Jacqueline Nash,Diane Brown,Mark Stacy,Kelli Williamson,Peter Novak,Robert G. Feldman,Cathi A. Thomas,W.R. Wayne Martin,Pam King,Germanine McInnes,Shaunna Caouette,Jo Belden,Andew Feigin,Jean Ayan,Barbara Shannon,Charles H. Adler,Stephanie Newman,Teri Radam,Myrna Schear,Naomi Santoni,Sharon Wortzel,Nancy Saton,Paul J. Tuite,Susan Rolandelli,Jody Lowery,Brenda Ebbitt,Adrienne Baranauskas,Michael J. Aminoff,Mirann DiMinno,Jessie Roth,Tracey Borst,Julie Hevezi,Carolyn Deloa,Tracey Tam,Anita Lopez,John M. Bertoni,Larisa I. Skrypnik,Carolyn Peterson,Mark Forrest Gordon,Roberta Winnick,Sharyn Parness,Joanne Hamann,Vincent Calabrese,Peggy Roberge,Paul Atchison,Cathy W. Allen,Susan Rolli,Arif Dalvi,Un Jung Kang,Judy Richman,Shirley Uy +137 more
TL;DR: Compared to delayed start, early initiation of rasagiline provided long‐term clinical benefit, even in the face of treatment with other dopaminergic agents.